Media Pack
News

Current Edition

Volume 7 issue 1

Upcoming Events

 
 

Advertisement

 
 
news

Cancer Research UK reveals innovation engine underpinned by £400m portfolio of cutting-edge discovery science

Cancer Research UK, the world's largest independent funder of cancer research, today (Tuesday 26th), unveiled Cancer Research Horizons, its new and ambitious approach...
28 April 2022 news cancer | Horizons
Continue Reading →
news

Novartis ups investment in gene therapy for the eye with $800M buyout

Novartis' offer comes three months after Gyroscope presented at a medical meeting early data from 13 patients who had been dosed with the gene therapy, called GT005, ...
7 January 2022 news buyout | eye
Continue Reading →
news

Sphere Fluidics closes a $40 million funding round led by Sofinnova Partners and Redmile Group

Cambridge, UK, 28 October 2021: Sphere Fluidics, a company that has developed and is commercialising single cell analysis systems underpinned by its proprietary picod...
2 November 2021 news Antibody | cell screening
Continue Reading →
news

Aptamer Group: UK Biotech Business Raises $2.2M Investment

Rapidly growing biotech business, Aptamer Group Ltd, has closed its Series A investment round after attracting international interest, securing $2.2m of funding from ...
29 June 2018 news $2.2M | Aptamer
Continue Reading →
news

Pfizer Expands Investment in Biotech through Pfizer Ventures

Company will spend $600 million on emerging/growth enterprises, with a focus on neuroscience. Pfizer Ventures, the venture capital arm of Pfizer, Inc, was founded in...
15 June 2018 news Biotech | expands
Continue Reading →
news

Chinese biopharma firm to create 400 jobs in Dundalk

WuXi Biologics will invest €325m in company’s first site outside of China Taoiseach Leo Varadkar at the announcement of...
1 May 2018 news biopharma | chinese
Continue Reading →
news

ADC Bio secures £1.14m investment from Downing LLP to finance innovative bioconjugation and US expansion

Funding earmarked for US market penetration and development of groundbreaking upstream bioconjugation approach ADC Biotechnology (ADC Bio), announces that it has sec...
24 April 2018 news ADC Bio | Downing LLP
Continue Reading →
 
 
IBI-white.png

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Facebook Linkedin
Bio Pharmaceutical Media © 2024, All Rights Reserved – Powered by Teksyte